Skip to main content
Award Ceremony, SxDiagnostics
The two founders, Carolyn Krause (l) and Susanne Schmidt (r) at the award ceremony, with Heike Marzen, Managing Director of the Dortmund Economic Development Agency and Alexander Kalouti, Mayor of the City of Dortmund
© Wirtschaftsförderung Dortmund / Andreas Buck

News categories: Honors & Funding

start2grow start-up competition awards “SxDiagnostics”

The “SxDiagnostics” project from the University of Bonn and the University Hospital Bonn (UKB) prevailed against over 100 competing teams in the start2grow competition and placed in the (shared) 4th to 10th spots. Start2grow is organized nationwide by the Dortmund Economic Development Agency and celebrated its 25th anniversary this year.

“SxDiagnostics,” led by Dr. Susanne Schmidt and Carolyn Krause, will use the prize money to further develop its innovative “SIRS chip” for detecting certain inflammatory responses towards market-readiness. This blood-based method can be used to assess the risk of systemic inflammatory response syndrome (SIRS). SIRS is a life-threatening immune response that can occur after invasive surgery and lead to death. The resulting SIRS prognosis helps physicians implement advanced therapies against SIRS prior to surgery, thereby saving lives.

Start-up Momentum from the Medical Field

“We were thrilled to receive the start2grow award! Now we’re highly motivated to continue working on our business and financing plans and are looking for business administrators, sales professionals, lawyers, and regulatory experts who can actively support us in building our start-up,” says Dr. Susanne Schmidt. She heads the Immune Monitoring & Genomics working group at the Institute of Clinical Chemistry and Clinical Pharmacology at the UKB. With her start-up project, she has already secured a GO-Bio initial grant from the BMFTR and a prototyping grant from the University of Bonn in 2025. The transfer teams from the Transfer Center enaCom and the Faculty of Medicine are supporting her on her path to founding the company.

Awards Ceremony in Dortmund

For the grand finale of start2grow 2025, held in Dortmund in March 2026, 20 selected teams were invited to present their business models to a panel of experts from the business, academic, and financial sectors. Among the top 10 teams, SxDiagnostics is the only one from the medical field. The top three spots went to the start-ups Spree Monitoring GmbH—a monitoring system for bridges—cargovibe UG—solutions for truck drivers—and wailand—an AI platform for engineers. All participants are supported by experienced coaches and benefit from expert knowledge, networks, and a variety of events.

About start2grow

The nationwide start-up competition start2grow, organized by the Dortmund Economic Development Agency, supports founders and start-ups with innovative and technology-driven business models.

Contact

Dr. Susanne Schmidt
Institute of Clinical Chemistry and Clinical Pharmacology
University Hospital Bonn (UKB)
mail: susanne.schmidt@uni-bonn.de
phone: +49 228 28712102

website SxDiagnostics

Related news

With funding from the Corona Foundation, Dr Christina Mayer (right) is establishing her own junior research group and developing the field of neurovisual diagnostics at the Department of Neurology at UKB, headed by Prof Anne-Katrin Pröbstel (left).

News categories: Honors & Funding

The Retina as a Window into the Early Detection of Brain Diseases

—The retina is the only part of the central nervous system that can be examined non-invasively and at high resolution in living humans. Dr Christina Mayer and her team at Bonn University Hospital (UKB) and the University of Bonn aim to use this unique feature to detect inflammatory and vascular diseases of the brain earlier and more accurately, and to better understand how they develop. The Corona Foundation is providing €1 million to establish her junior research group. The programme gives outstanding early-career researchers the opportunity to qualify for a university professorship.
View entry
Prof. Joanna Kalucka joins Bonn as a Mercator Fellow and investigates how metabolic and inflammatory processes affect the inner lining of blood vessels.

News categories: Honors & Funding

Joanna Kalucka Joins Bonn as a Mercator Fellow

—Joanna Kalucka, Associate Professor at Aarhus University’s Department of Biomedicine, will join the Collaborative Research Centre (CRC) 1454 “Metaflammation and Cellular Programming” at the University of Bonn and Bonn University Hospital (UKB) as a Mercator Fellow Global from 2027. The German Research Foundation (DFG) is funding her fellowship through the “1000 Heads Plus” programme of the Federal Ministry of Research, Technology and Space (BMFTR).
View entry
Prof. Christian Henneberger, Direktor des Instituts für Zelluläre Neurowissenschaften I am UKB, und Prof. Susanne Schoch McGovern,
Prof. Christian Henneberger, Direktor des Instituts für Zelluläre Neurowissenschaften I am UKB, und Prof. Susanne Schoch McGovern, - Direktorin des Instituts für Zelluläre Neurowissenschaften II am UKB, sind Sprecher und stellvertretende Sprecherin der neuen DFG-Forschungsgruppe FOR 5987. Der Forschungsverbund untersucht, wie Botenstoffe Informationen im Gehirn innerhalb und außerhalb von Synapsen übertragen.

News categories: Honors & Funding

How Far Do Signalling Molecules Act Beyond the Boundaries of a Synapse?

—The German Research Foundation (DFG) is establishing a new Research Unit entitled “Inside and Outside the Synapse: Challenging Dogmas of Synaptic Signalling and Neuromodulation.” The research consortium is headed by Prof. Christian Henneberger from Bonn University Hospital (UKB) and the University of Bonn, with Prof. Susanne Schoch McGovern, also from the UKB and the University of Bonn. Together with researchers from the UKB, the University of Bonn, the DZNE and the University of Göttingen, they will investigate how signalling molecules transmit information in the brain.
View entry

Back to the news overview